Senolytic Drugs Market is expected to grow at a CAGR of 30.54% through 2031
Global Senolytic Drugs Market is
driven by advancing pharmaceutical industry in the forecast period, 2027-2031.
According to TechSci Research report, “Senolytic
Drugs Market - Global Industry Size, Share, Trends, Opportunity and
Forecast, 2021-2031”, the Global Senolytic Drugs Market will grow from USD 299.14 Million in 2025 to USD 1480.25 Million by 2031 at a 30.54% CAGR. The rapidly advancing healthcare sector and the expanding pharmaceutical industry are further driving growth in the global senolytic drugs market over the next five years.
A surge in demand for advanced pharmaceuticals and therapeutics in major economies is expected to further support growth in the global senolytic drugs market over the next five years. Multiple market players have invested in research and are rapidly increasing their financial support for research institutes and academic centers dedicated to designing anti-aging and senolytic drugs, thereby supporting the growth of the global senolytic drugs market over the next five years.
The increasing incidence of chronic diseases such as cardiovascular diseases, neurodegenerative diseases, and chronic obstructive pulmonary disease (COPD) is also increasing demand for senolytic drugs, thereby supporting growth in the global senolytic drugs market through 2027. Rapidly growing cases of the geriatric population suffering from high blood pressure, diabetes, Alzheimer's disease, and Parkinson's disease are related to the growing age among humans.
The increasing global geriatric population, which may exceed 1 billion in the next 30 years, is also a major driver of the projected growth of the global senolytic drugs market over the next 5 years.
Although stringent rules and regulations governing FDA approvals and clinical trials for developing senolytic drugs may impose a modest restraint on the growth of the global senolytic drugs market in the future.
Browse over XX
market data Figures spread through 110 Pages
and an in-depth TOC on "Global Senolytic Drugs Market"
https://www.techsciresearch.com/report/senolytic-drugs-market/8205.html
The global senolytic drugs market is segmented by type, application, distribution channel, region, and competitive
landscape. Based on type, the market is fragmented into FOXO4-related peptides,
bcl-2 Family Inhibitors, Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib
& Quercetin, and others. Dasatinib,
Quercetin, Fisetin and Navitoclax are some of the primarily discovered
senolytic drugs through hypothesis.
Pre-clinical functions of the of the senolytic drugs were designed to be
preventive toward cancers, and cardiovascular, neuropsychiatric, liver, kidney,
musculoskeletal, lung, eye, hematological, metabolic and skin disorders. Also,
clinical trials of these drugs against diabetes, idiopathic pulmonary fibrosis,
Alzheimer’s disease, COVID-19, osteoarthritis, osteoporosis, eye disease, etc. are
continued. The studies are still being conducted and commercialization of these
drugs have still not started.
Market segmentation based on application, bifurcates into longevity,
senescence inhibition, cardiovascular diseases, neural degenerative diseases,
and others. Longevity is anticipated to hold the largest revenue shares of the
market and dominate the market segment in the upcoming five years on the
account of increasing demand for the pharmaceutical products that can aid
healthy lifespan in humans. Rapidly increasing geriatric population of the
world is further driving the growth of the global senolytic drugs market in the
next five years.
Senescence inhibition is the process of killing the aged cells that are
not dividing and accumulating in a location forming tumorous lump. Usually,
senescence in cells is a stress response mechanism induced by different type of
bodily responses like telomere attrition, DNA damage, and oncogenic mutations,
etc. Available therapeutics target such senescent cells act on specific killing
of these cells by senolytic process, specific inhibition of the secretory
phenotype, and improving removal of senescent cells by immune system.
Some of the market players, dominating the global senolytic drugs market
are:
- Unity Biotechnology
- Cleara Biotech
- Gero LLC
- Novartis AG
- Sierra Oncology
- Senolytic Therapeutics Inc
- Vera Therapeutics
- FoXBio Inc
- Numeric Biotech
- Agex Therapeutics
The existing market players
are highly invested in research and product development along with viable
service provisions for the consumers. New market entrants may adopt similar strategies, including mergers and acquisitions, to establish their brands.
Download Sample Report @
https://www.techsciresearch.com/sample-report.aspx?cid=8205
Customers can also request for 10%
free customization on this report.
“North America is anticipated to hold the largest revenue shares
of the market and dominate the regional analysis in the upcoming five years on
the account of expanding healthcare industry in the region. In the major
economies like the United States, and Canada, healthcare sector is booming on
the basis of increasing research and advancement in the pharmaceutical sector
in the countries along with the increasing investment in the pharmaceutical
designing, production and further research over senescent cells. Moreover,
government aid along with the FDA approvals for the senolytic drugs is further
anticipated to aid the growth of the global senolytic drugs market in the next
five years,” said Mr. Karan Chechi, Research Director with TechSci Research, a
research based global management consulting firm.
“Senolytic Drugs Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Type (FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib & Quercetin, Others), By Application (Longevity, Senescence Inhibition, Cardiovascular Diseases, Neural Degenerative Diseases, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region 2021-2031F”, has evaluated the future growth potential of global senolytic
drugs and provides statistics & information on market size, structure and
future market growth. The report aims to provide cutting-edge market intelligence and help decision-makers make sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in global senolytic drugs
market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/